⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19161216 | 0.84 | — | — | |
| SCHEMBL7052500 | 0.82 | — | — | |
| SCHEMBL7052495 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL19136656 | 0.82 | — | — | |
| SCHEMBL19198334 | 0.82 | — | — | |
| SCHEMBL7056938 | 0.76 | — | — | |
| SCHEMBL7056933 | 0.76 | — | — | |
| SCHEMBL776463 | 0.76 | — | — | |
| SCHEMBL7054205 | 0.76 | — | — | |
| SCHEMBL9474202 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| US-11616253-B2 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-03-28 | — | — | US | disclosed |
| US-20220278370-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| US-11367899-B2 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-06-21 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| CN-106848406-B | Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery | 三菱化学株式会社 | 2020-09-11 | — | — | CN | disclosed |
| CN-111048841-A | Nonaqueous electrolyte solution for secondary battery and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2020-04-21 | — | — | CN | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| EP-2144321-A1 | NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-01-13 | — | — | EP | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| CN-101432923-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP (JP) | 2009-05-13 | — | — | CN | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-6013675-A | ADMINISTERING TO THE MAMMAL A SUBSTITUTED GUANIDINE COMPOUNDS FOR TREATING THE DISEASE OF NERVOUS SYSTEM IN WHICH PATHOPHYSIOLOGY OF THE DISORDER INVOLVES EXCESSIVE ACTIVATION OF NERVE CELLS BY AGONIST OF METHYL ASPARTATE RECEPTORS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-01-11 | — | — | US | disclosed |
| US-5955507-A | ADMINISTERING TO A MAMMAL SUFFERING FROM NERVE CELL DEATH, STROKE, BRAIN OR SPINAL CORD TRAUMA, BRAIN OR SPINAL CORD ISCHEMIA OR HEART ATTACK AN EFFECTIVE AMOUNT OF A GUANADINE COMPOUND OR A SALT | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1999-09-21 | — | — | US | disclosed |
| US-5922772-A | PREVENTS OVERACTIVATION OF NMDA TYPE RECEPTORS BY GLUTAMATE; BINDS TO PCP TYPE RECEPTOR, ACTING AS A NONCOMPETITIVE ANTAGONIST, TREATMENT OF ALZHEIMER'S, PARKINSON'S, HUNTINGTON'S DISEASES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| EP-0739200-A4 | THERAPEUTIC SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE INC (US) | 1997-12-17 | — | — | EP | disclosed |
| EP-0739200-A1 | THERAPEUTIC SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1996-10-30 | — | — | EP | disclosed |
| WO-1995014461-A1 | THERAPEUTIC SUBSTITUTED GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1995-06-01 | — | — | WO | disclosed |